1. Medicine

Endothelial dysfunction in acute myocardial infarction: cell-autonomous metabolic reprogramming and oxidative stress

  1. Erika Zodda
  2. Olga Tura-Ceide
  3. Nicholas L Mills
  4. Josep Tarragó-Celada
  5. Marina Carini
  6. Timothy M Thomson  Is a corresponding author
  7. Marta Cascante  Is a corresponding author
  1. University of Barcelona, Spain
  2. Dr Josep Trueta University Hospital de Girona, Spain
  3. University of Edinburgh, United Kingdom
  4. Università degli Studi di Milano, Italy
  5. Spanish National Research Council, Spain
https://doi.org/10.7554/eLife.86260
Share this article
Cite this article
  1. Erika Zodda
  2. Olga Tura-Ceide
  3. Nicholas L Mills
  4. Josep Tarragó-Celada
  5. Marina Carini
  6. Timothy M Thomson
  7. Marta Cascante
(2023)
Endothelial dysfunction in acute myocardial infarction: cell-autonomous metabolic reprogramming and oxidative stress
eLife 12:e86260.
https://doi.org/10.7554/eLife.86260
  2. Download BibTeX
  3. Download .RIS

Abstract

Background: Compelling evidence has accumulated on the role of oxidative stress on the endothelial cell (EC) dysfunction underlying acute coronary syndrome. However, unveiling the underlying metabolic determinants has been hampered by the scarcity of appropriate cell models to address cell-autonomous mechanisms of ED dysfunction.

Methods: We have generated endothelial cells derived from thrombectomy specimens from patients affected with acute myocardial infarction (AMI) and conducted phenotypical and metabolic characterization, focused on central carbon metabolism.

Results: AMI-derived endothelial cells (AMIECs), but not control healthy coronary endothelial cells, display impaired growth, migration and tubulogenesis. Metabolically, AMIECs displayed augmented reactive oxygen species (ROS) and glutathione intracellular content, along with a diminished glucose consumption coupled to high lactate production. Consistent with diminished glycolysis in AMIECs, the protein levels of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase type 3, PFKFB3, were downregulated. In contrast, PFKFB4 levels were upregulated, suggesting a shunting of glycolysis towards the pentose phosphate pathway (PPP), supported by upregulation in AMIECs of G6PD, the key enzyme in the oxidative branch of the PPP. Further, the glutaminolytic enzyme GLS was upregulated in AMIECs, providing a mechanistic explanation for the observed increase in glutathione content. Finally, AMIECs displayed a significantly higher mitochondrial membrane potential than control ECs, which, together with high ROS levels, suggest a highly coupled mitochondrial activity in patient ECs.

Conclusions: We suggest high mitochondrial proton coupling underlies the abnormally high production of ROS, balanced by PPP- and glutaminolysis-driven synthesis of glutathione, as a primary, cell-autonomous abnormality driving EC dysfunction in AMI.

Funding: European Commission Horizon 2020; CIBER- Carlos III National Institute of Health, Spain; Ministerio de Economia y Competitividad (MINECO) and Ministerio de Ciencia e Innovación, Spain; Generalitat de Catalunya-AGAUR, Catalonia; Plataforma Temática Interdisciplinar Salud Global (PTI-SG), Spain; British Heart Foundation, UK.

Data availability

All data generated or analysed during this study are included in the manuscript.

Article and author information

Author details

  1. Erika Zodda

    Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain
    Competing interests
    Erika Zodda, The European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCAITNEJD grant (agreement No 675527): salary and research fundsGeneralitat de Catalunya-AGAUR: salary and research fundsPlataforma Temática Interdisciplinar - Salud Global: salary, travel expenses and research fundsMinisterio de Ciencia e Innovación, Spain: salary and research funds.

  2. Olga Tura-Ceide

    Department of Pulmonary Medicine, Dr Josep Trueta University Hospital de Girona, Girona, Spain
    Competing interests
    No competing interests declared.

  3. Nicholas L Mills

    BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    Nicholas L Mills, European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCA-ITN-EJD grant: research funds.

  4. Josep Tarragó-Celada

    Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.

  5. Marina Carini

    Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy
    Competing interests
    Marina Carini, European Commission Horizon 2020 research and innovation program under the MOGLYNET H2020-MSCA-ITN-EJD grant: research funds and travel expenses.

  6. Timothy M Thomson

    Institute for Molecular Biology of Barcelona, Spanish National Research Council, Barcelona, Spain
    For correspondence
    titbmc@ibmb.csic.es
    Competing interests
    Timothy M Thomson, CIBER- Carlos III National Institute of Health, Spain: research fundsMinisterio de Ciencia e Innovación, Spain: research fundsGeneralitat de Catalunya-AGAUR: research fundsPlataforma Temática Interdisciplinar - Salud Global: research funds.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4670-9440

  7. Marta Cascante

    Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain
    For correspondence
    martacascante@ub.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2062-4633

Funding

CIBER Carlos III National Institute of Health (CIBEREHD-CB17/04/00023)

  • Marina Carini
  • Timothy M Thomson

CIBER Carlos III National Institute of Health (CIBERES-CP17/00114)

  • Olga Tura-Ceide

Spanish Ministerio de Economia y Competitividad (PID2019-107139RB-C21)

  • Timothy M Thomson

Spanish Ministerio de Economia y Competitividad (PID2020-115051RB-I00)

  • Marina Carini

Generalitat de Catalunya-AGAUR (2021 SGR00350)

  • Marina Carini

Generalitat de Catalunya-AGAUR (2021 SGR1490)

  • Timothy M Thomson

Plataforma Temática Interdisciplinar - Salud Global (SGL2103019)

  • Timothy M Thomson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Acute myocardial infection patient-derived endothelial cells (AMIECs) were isolated from coronary atherothrombotic specimens in patients undergoing percutaneous coronary intervention with thrombectomy for the treatment of acute ST-segment elevation myocardial infarction (STEMI) at the Royal Infirmary of Edinburgh, Scotland, UK. The study protocol was approved by the Institutional Research Ethics Committee, and all subjects provided written informed consent.

Copyright

© 2023, Zodda et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 538
    views
  • 137
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Erika Zodda
  2. Olga Tura-Ceide
  3. Nicholas L Mills
  4. Josep Tarragó-Celada
  5. Marina Carini
  6. Timothy M Thomson
  7. Marta Cascante
(2023)
Endothelial dysfunction in acute myocardial infarction: cell-autonomous metabolic reprogramming and oxidative stress
eLife 12:e86260.
https://doi.org/10.7554/eLife.86260

Share this article

https://doi.org/10.7554/eLife.86260

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Medicine

    Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction

    Soo-Yeon Hwang, Kyung-Hwa Jeon ... Youngjoo Kwon
    Research Article

    HER2 overexpression significantly contributes to the aggressive nature and recurrent patterns observed in various solid tumors, notably gastric cancers. Trastuzumab, HER2-targeting monoclonal antibody drug, has shown considerable clinical success; however, readily emerging drug resistance emphasizes the pressing need for improved interventions in HER2-overexpressing cancers. To address this, we proposed targeting the protein-protein interaction (PPI) between ELF3 and MED23 as an alternative therapeutic approach to trastuzumab. In this study, we synthesized a total of 26 compounds consisting of 10 chalcones, 7 pyrazoline acetyl, and 9 pyrazoline propionyl derivatives, and evaluated their biological activity as potential ELF3-MED23 PPI inhibitors. Upon systematic analysis, candidate compound 10 was selected due to its potency in downregulating reporter gene activity of ERBB2 promoter confirmed by SEAP activity and its effect on HER2 protein and mRNA levels. Compound 10 effectively disrupted the binding interface between the ELF3 TAD domain and the 391–582 amino acid region of MED23, resulting in successful inhibition of the ELF3-MED23 PPI. This intervention led to a substantial reduction in HER2 levels and its downstream signals in the HER2-positive gastric cancer cell line. Subsequently, compound 10 induced significant apoptosis and anti-proliferative effects, demonstrating superior in vitro and in vivo anticancer activity overall. We found that the anticancer activity of compound 10 was not only restricted to trastuzumab-sensitive cases, but was also valid for trastuzumab-refractory clones. This suggests its potential as a viable therapeutic option for trastuzumab-resistant gastric cancers. In summary, compound 10 could be a novel alternative therapeutic strategy for HER2-overexpressing cancers, overcoming the limitations of trastuzumab.

    1. Medicine

    Enhancing bone regeneration and osseointegration using rhPTH(1-34) and dimeric R25CPTH(1-34) in an osteoporotic beagle model

    Jeong-Oh Shin, Jong-Bin Lee ... Jin-Woo Kim
    Research Article

    This study investigates the effects of two parathyroid hormone (PTH) analogs, rhPTH(1-34) and dimeric R25CPTH(1-34), on bone regeneration and osseointegration in a postmenopausal osteoporosis model using beagle dogs. Twelve osteoporotic female beagles were subjected to implant surgeries and assigned to one of three groups: control, rhPTH(1-34), or dimeric R25CPTH(1-34). Bone regeneration and osseointegration were evaluated after 10 weeks using micro-computed tomographic (micro-CT), histological analyses, and serum biochemical assays. Results showed that the rhPTH(1-34) group demonstrated superior improvements in bone mineral density, trabecular architecture, and osseointegration compared to controls, while the dimeric R25CPTH(1-34) group exhibited similar, though slightly less pronounced, anabolic effects. Histological and TRAP assays indicated both PTH analogs significantly enhanced bone regeneration, especially in artificially created bone defects. The findings suggest that both rhPTH(1-34) and dimeric R25CPTH(1-34) hold potential as therapeutic agents for promoting bone regeneration and improving osseointegration around implants in osteoporotic conditions, with implications for their use in bone-related pathologies and reconstructive surgeries.

    1. Medicine
    2. Neuroscience

    Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder

    Sophie Leclercq, Hany Ahmed ... Nathalie Delzenne
    Research Article

    Background:

    Alcohol use disorder (AUD) is a global health problem with limited therapeutic options. The biochemical mechanisms that lead to this disorder are not yet fully understood, and in this respect, metabolomics represents a promising approach to decipher metabolic events related to AUD. The plasma metabolome contains a plethora of bioactive molecules that reflects the functional changes in host metabolism but also the impact of the gut microbiome and nutritional habits.

    Methods:

    In this study, we investigated the impact of severe AUD (sAUD), and of a 3-week period of alcohol abstinence, on the blood metabolome (non-targeted LC-MS metabolomics analysis) in 96 sAUD patients hospitalized for alcohol withdrawal.

    Results:

    We found that the plasma levels of different lipids ((lyso)phosphatidylcholines, long-chain fatty acids), short-chain fatty acids (i.e. 3-hydroxyvaleric acid) and bile acids were altered in sAUD patients. In addition, several microbial metabolites, including indole-3-propionic acid, p-cresol sulfate, hippuric acid, pyrocatechol sulfate, and metabolites belonging to xanthine class (paraxanthine, theobromine and theophylline) were sensitive to alcohol exposure and alcohol withdrawal. 3-Hydroxyvaleric acid, caffeine metabolites (theobromine, paraxanthine, and theophylline) and microbial metabolites (hippuric acid and pyrocatechol sulfate) were correlated with anxiety, depression and alcohol craving. Metabolomics analysis in postmortem samples of frontal cortex and cerebrospinal fluid of those consuming a high level of alcohol revealed that those metabolites can be found also in brain tissue.

    Conclusions:

    Our data allow the identification of neuroactive metabolites, from interactions between food components and microbiota, which may represent new targets arising in the management of neuropsychiatric diseases such as sAUD.

    Funding:

    Gut2Behave project was initiated from ERA-NET NEURON network (Joint Transnational Call 2019) and was financed by Academy of Finland, French National Research Agency (ANR-19-NEUR-0003-03) and the Fonds de la Recherche Scientifique (FRS-FNRS; PINT-MULTI R.8013.19, Belgium). Metabolomics analysis of the TSDS samples was supported by grant from the Finnish Foundation for Alcohol Studies.